Tweenvest Stocks

Greenway Greenhouse Cannabis Corporation (CNSX: GWAY)

Health Care · Pharmaceuticals · CA

CA$0.09

+12.50% today · -55.0% 1Y

Greenway Greenhouse Cannabis Corporation (CNSX: GWAY) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $8.47M and employs 10 people.

Over the last twelve months the share price has lost 55.0%, trading between 0.07 and 0.22.

Tweenvest scores Greenway Greenhouse Cannabis Corporation across four factors: quality 37/100, value 38/100. Its strongest factor is value.

GWAY price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$8.47M
Revenue (TTM)
$5.68M
P/E
—
EPS
-0.02
Dividend yield
—
Beta (5Y)
0.07
52-week high
CA$0.22
52-week low
CA$0.07
Avg volume (3M)
—
Shares outstanding
134.08M
Employees
10
Next earnings
—

About Greenway Greenhouse Cannabis Corporation

Greenway Greenhouse Cannabis Corporation specializes in the cultivation, processing, and distribution of dried cannabis flower and kief. This company, established in 2018, operates out of Kingsville, Canada, and is a subsidiary of Sunrite Greenhouses Ltd.

ISIN
CA39679F2035
Founded
2018
Listed since
Sep 22, 2021
Exchange
Canadian National Stock Exchange
Currency
CAD
CompanyMarket capPriceDay
Vitura Health LimitedASX: VIT$8.79MAU$0.02-5.00%
Mediplantex National Pharmaceutical Joint Stock CompanyHNX: MED$8.68M₫——
CalciMedica, Inc.NasdaqCM: CALC$8.67M$1.27-2.31%
PharmaCielo Ltd.TSXV: PCLO$8.52MCA$0.060.00%
Central Pharmaceuticals Ltd.DSE: CENTRALPHL$8.37MTk8.60-4.44%
Curanex Pharmaceuticals IncNasdaqCM: CURX$8.33M$5.31+12.50%
Red White & Bloom Brands Inc.CNSX: RWB$8.25MCA$0.03-28.57%
Vilin Bio Med LimitedNSEI: VILINBIO$8.19MRs52.00-7.96%

Browse every Pharmaceuticals company →

Figures last refreshed Oct 11, 2026.